Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Patients harboring dolichoectactic vertebrobasilar (DVB) aneurysms are at risk of suffering
SAH, ischemic stroke, and/or brainstem compression and many patients are not offered invasive
treatment due to the futility of existing surgical methods. Consequently, there is demand for
development of medical therapy for DVB aneurysms